v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Shares
Additional
Paid-in
Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   158,009,541    
Beginning balance at Dec. 31, 2024 $ 27,087 $ 1 $ 328,655 $ (301,569)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common shares issued upon vesting of restricted share units, net of withholding 0      
Share-based compensation 187   187  
Net loss (6,212)     (6,212)
Ending balance (in shares) at Mar. 31, 2025   158,009,541    
Ending balance at Mar. 31, 2025 21,062 $ 1 328,842 (307,781)
Beginning balance (in shares) at Dec. 31, 2024   158,009,541    
Beginning balance at Dec. 31, 2024 27,087 $ 1 328,655 (301,569)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (12,500)      
Ending balance (in shares) at Jun. 30, 2025   158,617,767    
Ending balance at Jun. 30, 2025 14,929 $ 1 328,997 (314,069)
Beginning balance (in shares) at Mar. 31, 2025   158,009,541    
Beginning balance at Mar. 31, 2025 21,062 $ 1 328,842 (307,781)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common shares issued upon vesting of restricted share units, net of withholding (in shares)   608,226    
Common shares issued upon vesting of restricted share units, net of withholding (25)   (25)  
Share-based compensation 180   180  
Net loss (6,288)     (6,288)
Ending balance (in shares) at Jun. 30, 2025   158,617,767    
Ending balance at Jun. 30, 2025 $ 14,929 $ 1 328,997 (314,069)
Beginning balance (in shares) at Dec. 31, 2025 159,420,141 159,420,141    
Beginning balance at Dec. 31, 2025 $ (2,039) $ 1 329,270 (331,310)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common shares issued upon vesting of restricted share units, net of withholding (in shares)   263,812    
Common shares issued upon vesting of restricted share units, net of withholding (41)   (41)  
Share-based compensation 151   151  
Net loss (13,112)     (13,112)
Ending balance (in shares) at Mar. 31, 2026   159,683,953    
Ending balance at Mar. 31, 2026 $ (15,041) $ 1 329,380 (344,422)
Beginning balance (in shares) at Dec. 31, 2025 159,420,141 159,420,141    
Beginning balance at Dec. 31, 2025 $ (2,039) $ 1 329,270 (331,310)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of common stock options (in shares) 67,601      
Net loss $ (17,239)      
Ending balance (in shares) at Jun. 30, 2026 270,549,931 270,549,931    
Ending balance at Jun. 30, 2026 $ 56,064 $ 1 404,612 (348,549)
Beginning balance (in shares) at Mar. 31, 2026   159,683,953    
Beginning balance at Mar. 31, 2026 (15,041) $ 1 329,380 (344,422)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common shares issued upon vesting of restricted share units, net of withholding (in shares)   854,335    
Common shares issued upon vesting of restricted share units, net of withholding (278)   (278)  
Exercise of common stock options (in shares)   67,601    
Exercise of common stock options 22   22  
Share-based compensation 506   506  
Conversion of convertible debenture into common stock (in shares)   95,281,277    
Conversion of convertible debenture into common stock 64,982   64,982  
Issuance of common stock by private investment (in shares)   14,662,765    
Issuance of common stock by private investment 10,000   10,000  
Net loss $ (4,127)     (4,127)
Ending balance (in shares) at Jun. 30, 2026 270,549,931 270,549,931    
Ending balance at Jun. 30, 2026 $ 56,064 $ 1 $ 404,612 $ (348,549)